Protein transduction technology offers novel therapeutic approach for brain ischemia
- 31 May 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (5) , 216-218
- https://doi.org/10.1016/s0165-6147(03)00074-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Protection against ischemic brain injury by protein therapeuticsProceedings of the National Academy of Sciences, 2002
- Intravenous TAT–Bcl‐Xl is protective after middle cerebral artery occlusion in miceAnnals of Neurology, 2002
- Inhibition of Neuronal Apoptosis in Vitro and in Vivo Using TAT-Mediated Protein TransductionMolecular and Cellular Neuroscience, 2002
- In VivoDelivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal ApoptosisJournal of Neuroscience, 2002
- Protein transduction technologyCurrent Opinion in Biotechnology, 2002
- Neuroprotection Is Unlikely to Be Effective in Humans Using Current Trial DesignsStroke, 2002
- Programmed Cell Death in Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2001
- Life-or-death decisions by the Bcl-2 protein familyTrends in Biochemical Sciences, 2001
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Pathobiology of ischaemic stroke: an integrated viewPublished by Elsevier ,1999